Literature DB >> 19596052

Long-term green tea catechin administration prevents spatial learning and memory impairment in senescence-accelerated mouse prone-8 mice by decreasing Abeta1-42 oligomers and upregulating synaptic plasticity-related proteins in the hippocampus.

Q Li1, H F Zhao, Z F Zhang, Z G Liu, X R Pei, J B Wang, Y Li.   

Abstract

The senescence-accelerated mouse prone-8 (SAMP8) is characterized by early onset of learning and memory deficits along with spontaneous overproduction of soluble beta-amyloid peptide (Abeta) in the brain. In our study, 4 month old male SAMP8 mice were orally administered 0.05% and 0.1% green tea catechins (GTC, w/v) in drinking water for 6 months. We found that a supplementation with 0.05% or 0.1% GTC prevented spatial learning and memory impairments of mice in the Morris water maze. Better performance of GTC-treated mice was associated with decreased levels of Abeta(1-42) oligomers in the hippocampus. The activity of the protein kinase A/cAMP-response element binding protein (PKA/CREB) pathway, one of the molecular targets of Abeta oligomers which is crucial for late long-term potentiation and long-term memory formation, was significantly increased after GTC administration. We also found that chronic 0.05% or 0.1% GTC consumption prevented the reductions of three representative proteins of synaptic function and synaptic structure, including brain-derived neurotrophic factor(BDNF), post-synaptic density protein-95 (PSD95) and Ca(2+)/calmodulin-dependent protein kinase II (CaMKII). These results demonstrated that long-term 0.05% or 0.1% green tea catechin administration may prevent spatial learning and memory decline of SAMP8 mice by decreasing Abeta(1-42) oligomers and upregulating synaptic plasticity-related proteins in the hippocampus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19596052     DOI: 10.1016/j.neuroscience.2009.07.014

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  55 in total

1.  Selenium compounds prevent amyloid β-peptide neurotoxicity in rat primary hippocampal neurons.

Authors:  Gabriela Lorea Godoi; Lisiane de Oliveira Porciúncula; Janaína Fagundes Schulz; Fernanda Neutzling Kaufmann; João Batista da Rocha; Diogo Onofre Gomes de Souza; Gabriele Ghisleni; Hiram Larangeira de Almeida
Journal:  Neurochem Res       Date:  2013-09-08       Impact factor: 3.996

2.  D-Galactose High-Dose Administration Failed to Induce Accelerated Aging Changes in Neurogenesis, Anxiety, and Spatial Memory on Young Male Wistar Rats.

Authors:  Armando Cardoso; Sara Magano; Francisco Marrana; José P Andrade
Journal:  Rejuvenation Res       Date:  2015-08-20       Impact factor: 4.663

3.  The effect of soybean isoflavone on the dysregulation of NMDA receptor signaling pathway induced by β-amyloid peptides 1-42 in rats.

Authors:  Yuan-Di Xi; Juan Ding; Jing Han; Dan-Di Zhang; Jin-Meng Liu; Ling-Li Feng; Rong Xiao
Journal:  Cell Mol Neurobiol       Date:  2015-01-07       Impact factor: 5.046

Review 4.  Integrating cytosolic phospholipase A₂ with oxidative/nitrosative signaling pathways in neurons: a novel therapeutic strategy for AD.

Authors:  Grace Y Sun; Yan He; Dennis Y Chuang; James C Lee; Zezong Gu; Agnes Simonyi; Albert Y Sun
Journal:  Mol Neurobiol       Date:  2012-04-03       Impact factor: 5.590

Review 5.  Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system.

Authors:  Jaewon Lee; Dong-Gyu Jo; Daeui Park; Hae Young Chung; Mark P Mattson
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

Review 6.  Neurotrophin strategies for neuroprotection: are they sufficient?

Authors:  Joseph P Steiner; Avindra Nath
Journal:  J Neuroimmune Pharmacol       Date:  2014-03-08       Impact factor: 4.147

7.  Blueberry Supplementation Mitigates Altered Brain Plasticity and Behavior after Traumatic Brain Injury in Rats.

Authors:  Gokul Krishna; Zhe Ying; Fernando Gomez-Pinilla
Journal:  Mol Nutr Food Res       Date:  2019-05-29       Impact factor: 5.914

8.  Amyloid-β Peptide Is Needed for cGMP-Induced Long-Term Potentiation and Memory.

Authors:  Agostino Palmeri; Roberta Ricciarelli; Walter Gulisano; Daniela Rivera; Claudia Rebosio; Elisa Calcagno; Maria Rosaria Tropea; Silvia Conti; Utpal Das; Subhojit Roy; Maria Adelaide Pronzato; Ottavio Arancio; Ernesto Fedele; Daniela Puzzo
Journal:  J Neurosci       Date:  2017-06-16       Impact factor: 6.167

Review 9.  Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer's disease.

Authors:  Filipa I Baptista; Ana G Henriques; Artur M S Silva; Jens Wiltfang; Odete A B da Cruz e Silva
Journal:  ACS Chem Neurosci       Date:  2014-01-03       Impact factor: 4.418

10.  Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease.

Authors:  Marwa Aboukhatwa; Laura Dosanjh; Yuan Luo
Journal:  Mol Neurodegener       Date:  2010-03-12       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.